ArticleEuropean urology open science2026
Defining Long-term Success after Anterior Augmentation Urethroplasty: 10-yr Patient-reported and Objective Outcomes According to the Novel Stricture-fecta Criteria.
Article in European urology open science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective: There is a paucity of long-term data on patient-reported outcome measures (PROMs) after urethroplasty. We aimed to evaluate PROMs and retreatment-free survival more than 10 yr after anterior augmentation urethroplasty, using the recently established stricture-fecta criteria for standardized outcome reporting. Patients and methods: We retrospectively identified 97 men who underwent anterior augmentation urethroplasty between 2010 and 2013. Stricture characteristics were classified according to the Length, Segment, and Etiology system. Follow-up was performed via structured telephone interviews, and consenting patients completed a validated online survey at a single cross-sectional time point more than 10 yr after surgery. The survey included the Urethral Stricture Surgery (USS) PROM as well as instruments for urinary incontinence (ICIQ-UI SF), erectile function (IIEF-EF), and ejaculatory function (MSHQ-Ej). Retreatment-free survival was estimated using Kaplan-Meier analysis. The endpoints investigated met the trifecta criteria of standardized urethroplasty outcome reporting (stricture-fecta). Key findings and limitations: Median follow-up in 97 patients was 136 mo (95% confidence interval 133-138). Most strictures were >2 and ≤7 cm (66%) and bulbar (64%), predominantly iatrogenic (42%) or idiopathic (38%). Single-stage repair was performed in 90%. In total, 17 patients (18%) experienced recurrence, yielding 2-, 5-, and 10-yr retreatment-free survival rates of 90%, 86%, and 84%, respectively. Median USS PROM lower urinary tract symptoms score was 5/24, median ICIQ-UI SF 0/21, median IIEF-EF 19/30 (median modified IIEF-EF 24/30), and median MSHQ-Ej 28/35, indicating low urinary symptom burden and preserved sexual function. Mean EuroQol 5-Dimension (EQ-5D) index and EuroQol Visual Analogue Scale (EQ-VAS) were 0.936 and 78. Overall, 92% of patients reported being satisfied or very satisfied with their long-term outcomes. Limitations include the cross-sectional nature of long-term follow-up and potential nonresponse bias. Intervention: Augmentation urethroplasty. Conclusions and clinical implications: This first report of PROMs beyond 10 yr after anterior urethroplasty demonstrates durable retreatment-free survival, excellent long-term urinary and sexual function, and sustained patient satisfaction, providing a robust benchmark for current and emerging treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.